HENSON HEIDI 4
4 · Perspective Therapeutics, Inc. · Filed Dec 14, 2023
Insider Transaction Report
Form 4
HENSON HEIDI
Director
Transactions
- Award
Stock Options (right to buy)
2023-12-12+230,000→ 930,000 totalExercise: $0.24Exp: 2033-12-12→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]100% vests 12/12/2024.